US Executive Compensation Proxy SEC Filings — October 21, 2026

16-10-2026

Banzai International, Inc. filed a DEF 14A proxy statement seeking stockholder approval for two proposals: (1) an increase in authorized common stock from 350,000,000 to up to 850,000,000 total shares, and (2) authorization under Nasdaq Listing Rule 5635(d) for a potential public offering or financing of up to $14,000,000 of Class A common stock, potentially issued at a discount of up to 50% to the Minimum Price. The filing highlights the company's limited available authorized shares (approximately 96,724 available for equity plans after accounting for outstanding shares and 3,127,184 reserved for warrants), which the Board views as insufficient to support near-term financing needs, indicating dilution risk and liquidity pressure.

• · Proposed offering must be consummated within three months of stockholder approval
• · Company would not enter a transaction constituting a change of control under Nasdaq Listing Rule 5635(b)
• · Abstentions count as votes AGAINST; broker non-votes have no effect on outcome
• · Stockholders have no preemptive rights and no appraisal rights under Delaware law
• · Proposal 2 would permit zero-cash-exercise warrant provisions allowing exchange for shares in excess of the exercise entitlement
• · Company may use the offering to exchange trade debt or settle outstanding liabilities for securities
• · Board may abandon the authorized share amendment even after stockholder approval

19-10-2026

Jasper Therapeutics, Inc. (JSPRW) filed a definitive proxy statement for a virtual special meeting of stockholders on November 13, 2026, seeking approval of Nasdaq-required issuances of voting common stock upon conversion of non-voting preferred stock issued in the completed Kira Pharmaceuticals merger (closed July 16, 2026) and in a related private placement, plus ratification of director Patrick Crutcher's appointment and a possible adjournment proposal. The Board recommends voting FOR all proposals; stockholder approval of the merger itself is not required, and the company has 33,274,561 shares of voting common stock outstanding as of the September 28, 2026 record date.

• · Proposal 1 seeks Nasdaq Listing Rules 5635(a) and 5635(b) approval for common stock issuable on conversion of non-voting Preferred Stock issued in the Kira merger; stockholder approval of the merger itself was not required.
• · Proposal 2 seeks Nasdaq Listing Rule 5635(d) approval for common stock issuable on conversion of Preferred Stock sold in the private placement.
• · Proposal 3 asks stockholders to ratify the appointment of Patrick Crutcher to the Board.
• · Proposal 4 is a contingent adjournment proposal, to be used only if votes are insufficient for Proposals 1, 2 or 3.
• · The Reverse Stock Split has not been effected and no ratio has been selected; share and per-share figures in the proxy are not adjusted for it.
• · Proxy materials are expected to be mailed on or about October 23, 2026; the meeting is virtual at 10:00 a.m. Pacific Time via webcast.
• · Shareholders with questions may contact Alliance Advisors, LLC at 1-866-206-8305 or [email protected].

21-10-2026

Rezolute, Inc. (RZLT) filed its definitive DEF 14A proxy statement for the 2027 Annual Meeting of Stockholders, to be held virtually on December 2, 2026 at 3:00 p.m. Pacific Time, with a record date of October 5, 2026. Stockholders will vote on electing seven directors, ratifying Grant Thornton LLP as auditor for fiscal year ending June 30, 2027, a non-binding say-on-pay vote, an increase in authorized common stock from 165,000,000 to 225,000,000 shares, and an adjournment proposal. Management and board changes include Nevan Charles Elam serving as CEO and Acting Chairman, and the appointment of Sunil Karnawat as Chief Commercial Officer in August 2025.

• · Annual Meeting is virtual, accessible at www.virtualshareholdermeeting.com/RZLT2026
• · Proxy materials to be first sent to stockholders on or about October 23, 2026
• · Say-on-pay vote is advisory; if not approved, the compensation committee will reexamine executive compensation
• · Broker non-votes may be avoided if brokers exercise discretionary authority on the auditor ratification proposal
• · Dr. Roberts has served as CMO since June 1, 2022; Mr. Evans joined January 23, 2024; Dr. Karnawat joined August 18, 2025

21-10-2026

WhiteFiber, Inc. (WYFI) filed a definitive proxy statement on October 21, 2026 for its 2026 Annual General Meeting, to be held virtually on December 1, 2026 at 9:00 a.m. ET. Shareholders will vote on re-electing five existing directors and ratifying the independent registered public accounting firm; the Board unanimously recommends a vote FOR both proposals. Parent company Bit Digital, Inc. holds approximately 59.7% of outstanding ordinary shares and can approve all matters alone.

• · Record date for voting is October 6, 2026; the register of members will not be closed
• · Quorum requires shareholders holding at least one-third of votes outstanding; abstentions and broker non-votes count toward quorum but not toward votes cast
• · Beneficial owners wishing to attend must obtain a legal proxy and register by 11:59 p.m. ET on November 30, 2026
• · Each resolution requires a simple majority of votes cast by poll; no cumulative voting provisions exist
• · Proxy materials are available at https://www.transhare.com/whitefiber; Notice of Internet Availability mailed on or about October 21, 2026

21-10-2026

iM Global Partner Funds has filed a definitive DEF 14A proxy statement for a Special Meeting of Shareholders to be held January 15, 2027, asking shareholders to elect five Trustees to the Board of the Trust across eight fund series. The Board unanimously recommends a vote FOR the proposal, which is intended to give the Board flexibility to fill vacancies and keep a majority of Independent Trustees as required to rely on SEC Exemptive Rules. Trustee Harold M. Shefrin is retiring effective December 31, 2026, and the filing does not report any financial performance metrics.

• · Record date is September 25, 2026; shareholders must vote by January 15, 2027, with voting available by internet, phone, or mail.
• · Mr. Dumontier joined iMGP in September 2025 and was recommended by the Governance Committee; he would serve as the sole Interested Trustee.
• · Mr. Wainscott and Ms. Yang were appointed by the Board in 2024 and 2025 respectively and have not previously been elected by shareholders.
• · Mr. Shefrin is not standing for re-election, so the five nominees are Wainscott, Bird, DePriest, Yang and Dumontier.
• · The filing is a definitive proxy statement with no fee required, and it does not disclose any financial results, acquisitions, or regulatory actions.